PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-65.89%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-75.27%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-143.06%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-144.21%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-146.51%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-146.81%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-146.81%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
0.00%
Diluted share change of 0.00% while 6247.T is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-86.04%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-37.58%
Negative 5Y CAGR while 6247.T stands at 11.40%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-6.46%
Negative 3Y CAGR while 6247.T stands at 2.84%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
100.00%
Positive long-term OCF/share growth while 6247.T is negative. John Neff would see a structural advantage in sustained cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
91.24%
Net income/share CAGR at 50-75% of 6247.T's 142.90%. Martin Whitman might question if the firm’s product or cost base lags behind.
57.94%
5Y net income/share CAGR above 1.5x 6247.T's 19.65%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-150.33%
Negative 3Y CAGR while 6247.T is 194.02%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
208.94%
5Y equity/share CAGR above 1.5x 6247.T's 18.74%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
15.17%
3Y equity/share CAGR 1.25-1.5x 6247.T's 11.20%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-28.25%
Firm’s AR is declining while 6247.T shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
44.95%
Inventory growth well above 6247.T's 9.50%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.40%
Positive asset growth while 6247.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-4.48%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
45.19%
Debt growth of 45.19% while 6247.T is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
-100.00%
Our R&D shrinks while 6247.T invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
35.66%
SG&A growth well above 6247.T's 12.51%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.